Express Scripts Holding Co

Express Scripts — Merger or Acquisition (July 2011)

20 slides from Express Scripts's merger presentation, Jul 21, 2011

  1. Slide 1: Leading the Effort to Lower Drugs Costs for American Families

    Leading the Effort to Lower Drugs Costs for American Families

  2. Slide 2: Presenters

    Presenters George Paz Express Scripts, Inc. Chairman & Chief Executive Officer David Snow Medco Health Solutions, Inc. Chairman & Chief Executive Officer Jeff Hall Express Scripts, Inc. Executive Vice President & Chief Financial Officer

  3. Slide 3: Agenda

    Agenda Benefits of Merger Transaction Overview & Financial Consideration Q&A

  4. Slide 4: A combination the nation needs now: Lowers healthcare costs while improving patient care

    + A combination the nation needs now: Lowers healthcare costs while improving patient care

  5. Slide 5: Benefits of the Combination

    Benefits of the Combination Addresses national mandate for more affordable, higher quality healthcare Provides leadership and resources required to drive out waste and improve health outcomes Accelerates efforts to create greater efficiencies in healthcare Builds on our legacy of advancing healthcar

  6. Slide 6: Clients and Members Will Benefit

    Clients and Members Will Benefit Invite collaboration across the healthcare continuum to drive innovation Accelerates research, development and deployment of trend management tools Close gaps in care and achieve greater adherence through behavioral approach and clinical strengths Utilize expertise t

  7. Slide 7: The Right Transaction for Medco

    The Right Transaction for Medco Enhances Medco's successful track record of performance 22% EPS CAGR since spin-off in 2003 Built world-class specialty business Implemented numerous innovations (Therapeutic Resource Centers, DNA Direct, Medco Research Institute) Executed diversification strategy (UB

  8. Slide 8: Combining Complementary Expertise Via Consumerology and Clinical Innovation

    Combining Complementary Expertise Via Consumerology(r) and Clinical Innovation Clinical and data integration Specialty benefit services Care Coordination More than money One size does not fit all Key psychological forces Behavioral Insights TRCs driving increased adherence and compliance Specialist

  9. Slide 9: Building Shareholder Value Through Alignment

    Building Shareholder Value Through Alignment Complements Core Competencies Diversifies Business Enhances Specialty Pharmacy Platform Adds Additional Mail Order Capabilities Significant Synergy Potential + Improving health outcomes; delivering shareholder value Driving out waste Lowering costs

  10. Slide 10: Track Record of Execution and Innovation

    History of building shareholder value through successful acquisition strategy Note: Represents Adjusted EBITDA from continuing operations which is reconciled in tables in our earnings releases; adjusted to exclude non-recurring items. Track Record of Execution and Innovation Commitment to Building S

  11. Slide 11: Creating significant value through organic growth and strategic combinations

    Creating significant value: Successful track record of creating shareholder value through organic growth and strategic combinations +

  12. Slide 12: Transaction Overview

    $28.80 cash and 0.81 of a share of Express Scripts stock (fixed exchange ratio); total consideration of $29.1 billion Total value of $71.36 per Medco share based on Express Scripts' closing stock price on July 20, 2011 Transaction Overview Price Premium Ownership Anticipated Closing First half of 20

  13. Slide 13: Significant Financial Benefits

    Significant Financial Benefits Slightly accretive in first full year; moderately accretive post integration $1 billion of synergies when fully integrated Maintains Express Scripts' Strong Financial Profile Cash Flow: $4 billion+ of annual free cash flow post integration Capex: Disciplined capex depl

  14. Slide 14: Commitment to De-Leveraging

    Proven success integrating strategic acquisitions and reducing leverage rapidly $1,268m $460m $715m $466m $333m $251m NextRx $4,675m Note: Represents Adjusted EBITDA from continuing operations which is reconciled in tables in our earnings releases; adjusted to exclude non-recurring items. Track Reco

  15. Slide 15: Regulatory Approval

    Regulatory Approval Significant benefits in the public interest Lowers costs and improves outcomes for clients and members Improves the overall quality of healthcare by ensuring proper compliance, avoiding adverse reactions and providing customers the feedback to live healthier lives Facilitates coo

  16. Slide 16: Roadmap to Completion

    Roadmap to Completion Complete required filings Special meetings for Express Scripts and Medco shareholder approval Receive regulatory approvals Hart-Scott-Rodino Transaction expected to be completed in the first half of 2012

  17. Slide 17: Forward Looking Statements

    FORWARD LOOKING STATEMENTS Cautionary Note Regarding Forward-Looking Statements This material may include forward-looking statements, both with respect to us and our industry, that reflect our current views with respect to future events and financial performance. Statements that include the words "e

  18. Slide 18: Forward Looking Statements (Continued)

    FORWARD LOOKING STATEMENTS (Continued) TRANSACTION-RELATED FACTORS Uncertainty as to whether Express Scripts, Inc. (Express Scripts) will be able to consummate the transaction with Medco Health Solutions, Inc. (Medco) on the terms set forth in the merger agreement; The ability to obtain governmental

  19. Slide 19: Additional Information and Where to Find It

    ADDITIONAL INFORMATION AND WHERE TO FIND IT This communication is not a solicitation of a proxy from any stockholder of Express Scripts, Medco or Aristotle Holding, Inc. In connection with the Agreement and Plan of Merger among Medco, Express Scripts, Aristotle Holding, Inc., Plato Merger Sub Inc. a

  20. Slide 20: Leading the Effort to Lower Drugs Costs for American Families

    Leading the Effort to Lower Drugs Costs for American Families

Express Scripts — Merger or Acquisition (July 2011) on 6ix